Type I interferon limits central nervous system autoimmunity by modulating the microRNA-21–FOXO1 axis in pathogenic T helper 17 cells | Science Translational Medicine
Type I interferon limits central nervous system autoimmunity by regulating microRNA-21 and pathogenic T helper 17 cell development.
